Search alternatives:
significantly increased » significant increase (Expand Search)
significant decrease » significant increase (Expand Search)
increased decrease » increased release (Expand Search), increased crash (Expand Search)
significantly increased » significant increase (Expand Search)
significant decrease » significant increase (Expand Search)
increased decrease » increased release (Expand Search), increased crash (Expand Search)
-
241
Presentation 1_Decreased brain-derived neurotrophic factor expression in chronic kidney disease: integrated clinical and experimental evidence.pptx
Published 2025“…</p>Conclusion<p>This study integrated meta-analysis, murine model validation, and single-cell transcriptomic profiling to demonstrate a significant reduction of BDNF in CKD. Furthermore, renal BDNF expression decreased locally, predominantly originating from proximal tubule cells, macrophages, and podocytes, possibly epigenetically inhibited by the upregulation of lnc RNA Bdnf-as.…”
-
242
HFD decreases intermediate-term memory.
Published 2025“…(C) Food intake was not significantly different between ND- and HFD-fed flies during the 1 hour. …”
-
243
-
244
-
245
Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf
Published 2025“…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”
-
246
Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf
Published 2025“…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”
-
247
Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf
Published 2025“…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”
-
248
Presentation 1_Prehospital tranexamic acid decreases early mortality in trauma patients: a systematic review and meta-analysis.pdf
Published 2025“…</p>Conclusion<p>Prehospital TXA decreases early (24-h) mortality in trauma patients without a significant increase in the risk of VTE and other complications, and further studies are still needed to improve and optimize its management strategy.…”
-
249
-
250
-
251
-
252
-
253
-
254
-
255
Changes in mRNA expression of Caspase-3, ALDH2, Bcl-2, Bax and Bcl-2/Bax in three groups.
Published 2024Subjects: -
256
-
257
Comparison of myocardial LC3 immunofluorescence staining of three groups (×400, scale bar = 10μm).
Published 2024Subjects: -
258
-
259
-
260
Comparison of Beclin1, P62 and LC3B(II/I) protein expression levels in three groups.
Published 2024Subjects: